Systemic sclerosis. Part I: epidemiology, diagnosis and therapy.
作者信息
Efrimescu C I, Donnelly S, Buggy D J
机构信息
Mater Misericordiae University Hospital, Dublin, Ireland.
University College Dublin, Dublin, Ireland.
出版信息
BJA Educ. 2023 Feb;23(2):66-75. doi: 10.1016/j.bjae.2022.10.004. Epub 2023 Jan 10.
Abstract
摘要
相似文献
1
Systemic sclerosis. Part I: epidemiology, diagnosis and therapy.
BJA Educ. 2023 Feb;23(2):66-75. doi: 10.1016/j.bjae.2022.10.004. Epub 2023 Jan 10.
2
Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
Am J Med Sci. 2023 Feb;365(2):198-204. doi: 10.1016/j.amjms.2022.01.023. Epub 2022 Mar 8.
3
[An up date on pulmonary hypertension related to systemic sclerosis].
Przegl Lek. 2005;62(8):813-7.
4
Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2021 Apr 6;10(7):e015816. doi: 10.1161/JAHA.119.015816. Epub 2021 Mar 24.
5
Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis.
Clin Rheumatol. 2020 May;39(5):1687-1691. doi: 10.1007/s10067-020-04953-4. Epub 2020 Jan 22.
6
Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.
Curr Opin Rheumatol. 2004 Nov;16(6):723-32. doi: 10.1097/01.bor.0000144760.37777.fa.
7
Systemic Sclerosis and Pulmonary Disease.
Adv Exp Med Biol. 2021;1303:173-182. doi: 10.1007/978-3-030-63046-1_10.
8
A review of exercise pulmonary hypertension in systemic sclerosis.
J Scleroderma Relat Disord. 2019 Oct;4(3):225-237. doi: 10.1177/2397198319851653. Epub 2019 Jun 14.
9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
Heart Fail Clin. 2023 Jan;19(1):45-54. doi: 10.1016/j.hfc.2022.08.016.
10
Systemic sclerosis. Part II: perioperative considerations.
BJA Educ. 2023 Mar;23(3):101-109. doi: 10.1016/j.bjae.2022.10.003. Epub 2023 Jan 4.
引用本文的文献
1
The effect of self-management program performed via telerehabilitation on occupational performance and satisfaction of individuals with systemic sclerosis.
Br J Occup Ther. 2025 Mar;88(3):185-192. doi: 10.1177/03080226241283288. Epub 2024 Sep 20.
2
Systemic sclerosis. Part II: perioperative considerations.
BJA Educ. 2023 Mar;23(3):101-109. doi: 10.1016/j.bjae.2022.10.003. Epub 2023 Jan 4.
本文引用的文献
1
Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis.
Adv Rheumatol. 2022 Mar 30;62(1):10. doi: 10.1186/s42358-022-00239-2.
2
French recommendations for the management of systemic sclerosis.
Orphanet J Rare Dis. 2021 Jul 26;16(Suppl 2):322. doi: 10.1186/s13023-021-01844-y.
3
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.
Arthritis Rheumatol. 2021 Jul;73(7):1301-1310. doi: 10.1002/art.41668. Epub 2021 May 25.
4
Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis.
Arthritis Res Ther. 2021 Jan 19;23(1):34. doi: 10.1186/s13075-021-02421-1.
5
An Update on Systemic Sclerosis and its Perioperative Management.
Curr Anesthesiol Rep. 2020;10(4):512-521. doi: 10.1007/s40140-020-00411-8. Epub 2020 Aug 29.
6
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28.
7
Drugs in phase I and phase II clinical trials for systemic sclerosis.
Expert Opin Investig Drugs. 2020 Apr;29(4):349-362. doi: 10.1080/13543784.2020.1743973. Epub 2020 Mar 25.
8
Is heart transplantation a valuable option in patients with diffuse systemic sclerosis and primary cardiac involvement?
Clin Case Rep. 2019 Dec 19;8(1):137-141. doi: 10.1002/ccr3.2600. eCollection 2020 Jan.
9
Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing.
J Clin Sleep Med. 2019 Nov 15;15(11):1665-1669. doi: 10.5664/jcsm.8036.
10
Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease.
Clin Epidemiol. 2019 Apr 18;11:257-273. doi: 10.2147/CLEP.S191418. eCollection 2019.
Zotero 插件